348 related articles for article (PubMed ID: 32411773)
1. Analysis of expression differences of immune genes in non-small cell lung cancer based on TCGA and ImmPort data sets and the application of a prognostic model.
Sun L; Zhang Z; Yao Y; Li WY; Gu J
Ann Transl Med; 2020 Apr; 8(8):550. PubMed ID: 32411773
[TBL] [Abstract][Full Text] [Related]
2. A prognostic model of non small cell lung cancer based on TCGA and ImmPort databases.
Yang D; Ma X; Song P
Sci Rep; 2022 Jan; 12(1):437. PubMed ID: 35013450
[TBL] [Abstract][Full Text] [Related]
3. Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma.
Li Y; Shen R; Wang A; Zhao J; Zhou J; Zhang W; Zhang R; Zhu J; Liu Z; Huang JA
Front Cell Dev Biol; 2021; 9():648806. PubMed ID: 33869203
[TBL] [Abstract][Full Text] [Related]
4. Identification and development of an independent immune-related genes prognostic model for breast cancer.
Chen L; Dong Y; Pan Y; Zhang Y; Liu P; Wang J; Chen C; Lu J; Yu Y; Deng R
BMC Cancer; 2021 Mar; 21(1):329. PubMed ID: 33785008
[TBL] [Abstract][Full Text] [Related]
5. Construction of an immune-related gene prognostic model with experimental validation and analysis of immune cell infiltration in lung adenocarcinoma.
Yang J; Tang C; Li C; Li X; Yang W
Oncol Lett; 2024 Jul; 28(1):297. PubMed ID: 38751753
[TBL] [Abstract][Full Text] [Related]
6. A Novel Hypoxia-Related Gene Signature with Strong Predicting Ability in Non-Small-Cell Lung Cancer Identified by Comprehensive Profiling.
Yang H; Wang Z; Gong L; Huang G; Chen D; Li X; Du F; Lin J; Yang X
Int J Genomics; 2022; 2022():8594658. PubMed ID: 35634481
[TBL] [Abstract][Full Text] [Related]
7. Role of ALOX5 in non-small cell lung cancer: A potential therapeutic target associated with immune cell infiltration.
Zhao Q; Sun Z; Pan Y; Jing Q; Li W; Wang C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):311-322. PubMed ID: 37164914
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the Significance of Immune Cell Infiltration and Prognosis of Non-Small-Cell Lung Cancer by Bioinformatics.
Sun H; Sui B; Li Y; Yan J; Cao M; Zhang L; Liu S
J Healthc Eng; 2021; 2021():3284186. PubMed ID: 34603645
[TBL] [Abstract][Full Text] [Related]
9. Identification and validation of the prognostic value of immune-related genes in non-small cell lung cancer.
Li R; Liu X; Zhou XJ; Chen X; Li JP; Yin YH; Qu YQ
Am J Transl Res; 2020; 12(9):5844-5865. PubMed ID: 33042464
[TBL] [Abstract][Full Text] [Related]
10. [Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma].
Zhou J; Wang X; Li Z; Jiang R
Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):557-566. PubMed ID: 34256900
[TBL] [Abstract][Full Text] [Related]
11. Integrative bioinformatics approaches to establish potential prognostic immune-related genes signature and drugs in the non-small cell lung cancer microenvironment.
Zhou J; Shi S; Qiu Y; Jin Z; Yu W; Xie R; Zhang H
Front Pharmacol; 2023; 14():1153565. PubMed ID: 37077811
[No Abstract] [Full Text] [Related]
12. Screening of prognostic immune genes and establishment of prognostic model of cervical adenocarcinoma based on bioinformatics analysis.
Yi Y; Sheng J; Nie J
Ann Transl Med; 2022 May; 10(10):548. PubMed ID: 35722389
[TBL] [Abstract][Full Text] [Related]
13. The Combined Detection of Immune Genes for Predicting the Prognosis of Patients With Non-Small Cell Lung Cancer.
Tian WJ; Liu SS; Li BR
Technol Cancer Res Treat; 2020; 19():1533033820977504. PubMed ID: 33256552
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of the long noncoding RNA HOXA11-AS gene interaction regulatory network in NSCLC cells.
Zhang Y; He RQ; Dang YW; Zhang XL; Wang X; Huang SN; Huang WT; Jiang MT; Gan XN; Xie Y; Li P; Luo DZ; Chen G; Gan TQ
Cancer Cell Int; 2016; 16():89. PubMed ID: 27980454
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the tumor immune environment identifies an immune gene set-based prognostic signature in non-small cell lung cancer.
Guo G; Yang L; Wen Y; Wang G; Zhang R; Zhao D; Huang Z; Zhang X; Lin Y; Zhang L
Ann Transl Med; 2022 Jan; 10(1):15. PubMed ID: 35242860
[TBL] [Abstract][Full Text] [Related]
16. Identifying the hub genes in non-small cell lung cancer by integrated bioinformatics methods and analyzing the prognostic values.
Wang T; Chen X; Jing F; Li Z; Tan H; Luo Y; Shi H
Pathol Res Pract; 2021 Dec; 228():153654. PubMed ID: 34749208
[TBL] [Abstract][Full Text] [Related]
17. Tumor microenvironment related novel signature predict lung adenocarcinoma survival.
Chen J; Zhou R
PeerJ; 2021; 9():e10628. PubMed ID: 33520448
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of lymph nodes metastasis associated genes in cervical cancer and its significance in treatment and prognosis.
Yang P; Ruan Y; Yan Z; Gao Y; Yang H; Wang S
BMC Cancer; 2021 Nov; 21(1):1230. PubMed ID: 34789197
[TBL] [Abstract][Full Text] [Related]
19. Using Machine Learning Modeling to Explore New Immune-Related Prognostic Markers in Non-Small Cell Lung Cancer.
Xu J; Nie H; He J; Wang X; Liao K; Tu L; Xiong Z
Front Oncol; 2020; 10():550002. PubMed ID: 33215029
[TBL] [Abstract][Full Text] [Related]
20. Construction and Validation of an Immune-Related Risk Score Model for Survival Prediction in Glioblastoma.
Ren W; Jin W; Liang Z
Front Neurol; 2022; 13():832944. PubMed ID: 35370869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]